Pricing Log in Create free account
Saturday 17 October 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Abbott Laboratories (ABT) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Abbott Laboratories (ABT) trades at a price to free cash flow of 23.3×. Over the past ten years it has ranged from 19.5× (May 2026) to 44.3× (November 2020); the current reading is higher than 13% of that period. That is in line with the Medical Devices industry median of 23.7× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 29.5× (4.81%)
FY2024 31.0× (17.98%)
FY2023 37.8× 53.49%
FY2022 24.6× (14.79%)
FY2021 28.9× (14.82%)
FY2020 33.9× (0.67%)
FY2019 34.1× 31.73%
FY2018 25.9× 12.37%
FY2017 23.1× (16.74%)
FY2016 27.7× (23.47%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 20.2× (16.76%)
Mar 2026 24.2× (17.80%)
Dec 2025 29.5× (12.56%)
Sep 2025 33.7× (3.62%)
42 more quarters

Against its own ten years

Low 19.5× High 44.3×
Ten-year median 30.5×
Current reading's percentile 13

Price to free cash flow against peers

Company Price to free cash flow
PHG Koninklijke Philips N.V. compare 13.3×
BSX Boston Scientific Corporation compare 18.0×
MDT Medtronic PLC compare 19.8×
GEHC GE HealthCare Technologies Inc. compare 20.0×
STE STERIS plc compare 23.2×
ABT Abbott Laboratories 23.3×
DXCM DexCom, Inc. compare 23.4×
SYK Stryker Corporation compare 24.0×
EW Edwards Lifesciences Corporation compare 35.6×
Medical Devices industry median 23.7×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on ABT